chr17-2042736-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_080822.3(OVCA2):c.316C>A(p.Leu106Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000697 in 1,434,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080822.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OVCA2 | NM_080822.3 | c.316C>A | p.Leu106Met | missense_variant | 2/2 | ENST00000572195.3 | |
DPH1 | NM_001383.6 | c.*150C>A | 3_prime_UTR_variant | 13/13 | ENST00000263083.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OVCA2 | ENST00000572195.3 | c.316C>A | p.Leu106Met | missense_variant | 2/2 | 1 | NM_080822.3 | P1 | |
DPH1 | ENST00000263083.12 | c.*150C>A | 3_prime_UTR_variant | 13/13 | 1 | NM_001383.6 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000442 AC: 1AN: 226470Hom.: 0 AF XY: 0.00000814 AC XY: 1AN XY: 122916
GnomAD4 exome AF: 6.97e-7 AC: 1AN: 1434106Hom.: 0 Cov.: 32 AF XY: 0.00000140 AC XY: 1AN XY: 711906
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | The c.316C>A (p.L106M) alteration is located in exon 2 (coding exon 2) of the OVCA2 gene. This alteration results from a C to A substitution at nucleotide position 316, causing the leucine (L) at amino acid position 106 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at